CONAGRA BRANDS INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CONAGRA BRANDS INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | May 29, 2016 | $1.50B | Jul 15, 2016 |
| FY2015 | May 31, 2015 | $1.90B | Jul 17, 2015 |
| FY2014 | May 25, 2014 | $2.20B | Jul 16, 2014 |
| FY2014 | May 26, 2013 | $1.90B | Jul 16, 2014 |
| FY2014 | May 27, 2012 | $1.60B | Jul 16, 2014 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $11.61B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $12.05B | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $12.28B | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $11.54B | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $11.18B | Jul 13, 2023 |
| FY2020 | May 31, 2020 | $3.29B | Jul 24, 2020 |
| FY2020 | Feb 23, 2020 | $2.56B | Jul 24, 2020 |
| FY2020 | Nov 24, 2019 | $2.82B | Jul 24, 2020 |
| FY2020 | Aug 25, 2019 | $2.39B | Jul 24, 2020 |
| FY2020 | May 26, 2019 | $2.61B | Jul 24, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $3.00B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $3.33B | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $3.26B | Jul 10, 2025 |
| FY2020 | May 31, 2020 | $922.80M | Jul 24, 2020 |
| FY2020 | Feb 23, 2020 | $684.40M | Jul 24, 2020 |
| FY2020 | Nov 24, 2019 | $797.90M | Jul 24, 2020 |
| FY2020 | Aug 25, 2019 | $664.50M | Jul 24, 2020 |
| FY2020 | May 26, 2019 | $708.00M | Jul 24, 2020 |
| FY2020 | Feb 24, 2019 | $752.30M | Jul 24, 2020 |
| FY2020 | Nov 25, 2018 | $677.20M | Jul 24, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $1.15B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $347.20M | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $683.60M | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $888.20M | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $1.30B | Jul 13, 2023 |
| FY2020 | May 31, 2020 | $201.40M | Jul 24, 2020 |
| FY2020 | Feb 23, 2020 | $204.40M | Jul 24, 2020 |
| FY2020 | Nov 24, 2019 | $260.50M | Jul 24, 2020 |
| FY2020 | Aug 25, 2019 | $173.80M | Jul 24, 2020 |
| FY2020 | May 26, 2019 | $126.50M | Jul 24, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $1.36B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $852.80M | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $1.08B | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $1.59B | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $2.14B | Jul 13, 2023 |
| FY2022 | May 31, 2020 | $1.82B | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $1.64B | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $1.41B | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $1.24B | Jul 19, 2019 |
| FY2018 | May 29, 2016 | $1.22B | Jul 20, 2018 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $60.80M | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $61.40M | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $57.70M | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $53.40M | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $51.30M | Jul 13, 2023 |
| FY2022 | May 31, 2020 | $56.40M | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $56.10M | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $47.30M | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $44.60M | Jul 19, 2019 |
| FY2018 | May 29, 2016 | $59.60M | Jul 20, 2018 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $1.54B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $1.49B | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $1.43B | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $1.49B | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $1.40B | Jul 13, 2023 |
| FY2022 | May 31, 2020 | $1.62B | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $1.47B | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $1.40B | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $1.47B | Jul 19, 2019 |
| FY2018 | May 29, 2016 | $2.02B | Jul 20, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $1.69B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $2.02B | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $995.40M | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $1.18B | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $1.47B | Jul 13, 2023 |
| FY2022 | May 31, 2020 | $1.84B | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $1.13B | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $954.20M | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $1.17B | Jul 19, 2019 |
| FY2018 | May 29, 2016 | $1.26B | Jul 20, 2018 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $389.30M | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $388.10M | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $362.20M | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $464.40M | Jul 11, 2024 |
| FY2023 | May 30, 2021 | $506.40M | Jul 13, 2023 |
| FY2022 | May 31, 2020 | $369.50M | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $353.10M | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $251.60M | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $242.10M | Jul 19, 2019 |
| FY2018 | May 29, 2016 | $277.50M | Jul 20, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $20.93B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $20.86B | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $22.05B | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $22.44B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $22.20B | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $22.30B | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $22.21B | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $10.39B | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $10.10B | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $13.39B | Jul 21, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $12.00B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $12.35B | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $13.25B | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $13.57B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $13.56B | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $14.35B | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $14.75B | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $6.63B | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $6.02B | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $9.60B | Jul 21, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $8.93B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $8.44B | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $8.74B | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $8.79B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $8.55B | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $7.88B | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $7.38B | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $3.68B | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $3.99B | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $3.71B | Jul 21, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $10.50B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $10.33B | Jul 10, 2025 |
| FY2025 | May 28, 2023 | $10.85B | Jul 10, 2025 |
| FY2024 | May 29, 2022 | $11.26B | Jul 11, 2024 |
| FY2023 | May 31, 2021 | $11.34B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $11.34B | Jul 21, 2022 |
| FY2022 | May 31, 2020 | $11.33B | Jul 21, 2022 |
| FY2021 | May 26, 2019 | $11.36B | Jul 23, 2021 |
| FY2020 | May 27, 2018 | $4.48B | Jul 24, 2020 |
| FY2019 | May 28, 2017 | $4.28B | Jul 19, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $6.76B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $6.28B | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $6.60B | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $6.55B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $6.26B | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $5.47B | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $5.05B | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $4.74B | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $4.25B | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $3.22B | Jul 21, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $68.00M | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $77.70M | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $93.30M | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $83.30M | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $79.20M | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $553.30M | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $236.60M | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $128.00M | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $251.40M | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $798.10M | Jul 21, 2017 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | $7.26B | Jul 10, 2025 |
| FY2025 | May 26, 2024 | $7.51B | Jul 10, 2025 |
| FY2024 | May 28, 2023 | $8.60B | Jul 11, 2024 |
| FY2023 | May 29, 2022 | $8.80B | Jul 13, 2023 |
| FY2022 | May 30, 2021 | $8.30B | Jul 21, 2022 |
| FY2021 | May 31, 2020 | $9.75B | Jul 23, 2021 |
| FY2020 | May 26, 2019 | $10.68B | Jul 24, 2020 |
| FY2019 | May 27, 2018 | $3.54B | Jul 19, 2019 |
| FY2018 | May 28, 2017 | $2.97B | Jul 20, 2018 |
| FY2017 | May 29, 2016 | $5.44B | Jul 21, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | 2 | Jul 10, 2025 |
| FY2025 | May 26, 2024 | 0 | Jul 10, 2025 |
| FY2025 | May 28, 2023 | 1 | Jul 10, 2025 |
| FY2024 | May 29, 2022 | 1 | Jul 11, 2024 |
| FY2023 | May 30, 2021 | 2 | Jul 13, 2023 |
| FY2020 | May 31, 2020 | 0 | Jul 24, 2020 |
| FY2020 | Feb 23, 2020 | 0 | Jul 24, 2020 |
| FY2020 | Nov 24, 2019 | 0 | Jul 24, 2020 |
| FY2020 | Aug 25, 2019 | 0 | Jul 24, 2020 |
| FY2020 | May 26, 2019 | 0 | Jul 24, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | May 25, 2025 | 2 | Jul 10, 2025 |
| FY2025 | May 26, 2024 | 0 | Jul 10, 2025 |
| FY2025 | May 28, 2023 | 1 | Jul 10, 2025 |
| FY2024 | May 29, 2022 | 1 | Jul 11, 2024 |
| FY2023 | May 30, 2021 | 2 | Jul 13, 2023 |
| FY2020 | May 31, 2020 | 0 | Jul 24, 2020 |
| FY2020 | Feb 23, 2020 | 0 | Jul 24, 2020 |
| FY2020 | Nov 24, 2019 | 0 | Jul 24, 2020 |
| FY2020 | Aug 25, 2019 | 0 | Jul 24, 2020 |
| FY2020 | May 26, 2019 | 0 | Jul 24, 2020 |